Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BTGGF:US

10.6200 USD 0.5800 5.18%

As of 20:10:00 ET on 03/27/2015.

Snapshot for BTG PLC (BTGGF)

Open: 10.6200 Day's Range: 10.6200 - 10.6200 Volume: 386
Previous Close: 11.2000 52wk Range: 8.2000 - 12.5500 1-Yr Rtn: +15.81%

Stock Chart for BTGGF

No chart data available.
  • BTGGF:US 10.6200
  • 1M
  • 1Y
11.2000
Interactive BTGGF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTGGF

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 43.3308
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (03/2015) 0.1650
Est. PEG Ratio 1.7708
Market Cap (M USD) 4,054.47
Shares Outstanding (M) 381.78
30 Day Average Volume 223
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTGGF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for BTGGF

BTG plc licenses, develops and commercializes pharmaceuticals and has a pipeline of development programs targeting neurological and other disorders, including varicose veins. The Company also has a substantial and growing revenue stream of milestone payments and royalties from out-licensed products.

Pamela Louise MakinCEO/Executive DirectorRolf SoderstromCFO/Executive Director
Peter StratfordCTO:Interventional MedicineGuenter R JanhoferChief Medical Officer/Head:Dev
More Company Profile & Key Executives for BTGGF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil